BioNxt Solutions Announces Change of Directors
VANCOUVER, BC / ACCESSWIRE / October 3, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT), announces that Per...
Pharmaceutical
ZS Announces Launch of ZAIDYN™ Connected Health
ZS’s AI-powered platform now empowers teams to deliver a connected patient experience with individual need-based interventions and support.EVANSTON, Ill.--(BUSINESS WIRE)--ZS,...
Synchrony Symposium 2023 Advances Research and Clinical Care for Neurodevelopmental Disorders, Including Autism
Dr. Mario Capecchi, Nobel Laureate at University of Utah, to Deliver Keynote on Research to Understand Symptoms Prevalent in Individuals...
Massive Bio Pioneers Clinical Trial Recruitment Innovation with Strategic Support from Evernorth Health, Inc.
Elevating Global Patient Access to Clinical Trials through Revolutionary Collaboration and Advanced AI-Driven TechnologiesNEW YORK--(BUSINESS WIRE)--Massive Bio Inc., a trailblazing...
The Immunoglobulin National Society and ACHC Announce Partnership
LOS ANGELES, CA / ACCESSWIRE / October 3, 2023 / Immunoglobulin National Society (IgNS) announced today it is partnering with...
The 25 Top Client-Rated Technologies Exhibiting at Becker’s Health IT + Digital Health + RCM Meeting, 2023 Black Book Survey
Black Book Research acknowledges the top-performing healthcare technology companies within various revenue cycle management and digital health market segments based...
Single and Repeat Dose Clinical Study of neffy (epinephrine nasal spray) Published in the Journal of Allergy and Clinical Immunology
Figure 2: Systolic Blood Pressure (SBP) Mean change from baseline in SBP vs time. (A) Single dose. (B) Repeat dose....
Insider information: BBS-Bioactive Bone Substitutes Plc appoints Juliusz Rakowski as new CEO as BBS prepares for the commercial phase
BBS-Bioactive Bone Substitutes Plc, Company Announcement, Insider Information, 3 October 2023 at 4.00 p.m. (EET) Insider information: BBS-Bioactive Bone Substitutes...
Scilex Holding Company Provides Notice to All Record Holders and Beneficial Owners of Restricted Shares of Scilex Holding Company
PALO ALTO, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating...
Certified Testing & Data and Nova Analytic Labs to Launch New York Cannabis Testing Lab
ALBANY, N.Y., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Certified Testing & Data (CTND) and Nova Analytic Labs (Nova) announced a...
NeuroSigma Announces HSA Approval of the Monarch eTNS System in Singapore
LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced approval of the Monarch eTNS System by Singapore’s Health...
Groundbreaking Study Finds Natural Formulation by MDbio – The Doctors BrandTM Significantly Improves Sleep, Anxiety, Stress, and Overall Well-being
Radicle Science studied MDSleep in one of history’s largest clinical trials on a supplement brand’s sleep formulation.Los Angeles, CA, Oct....
Cannabix’s MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath
Cannabix Technologies Inc. Cannabix Technologies MSBS and BCU Figures 1 and 2 VANCOUVER, British Columbia, Oct. 03, 2023 (GLOBE NEWSWIRE)...
Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production
Begins revenue generation for “Camelina Seed Genetics to Biofuel” platformWOBURN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc....
Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent...
Disc Medicine Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy Volunteers
WATERTOWN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
Zylö accepted into NYU’s exclusive Endless Frontier Labs mentorship program
GREENVILLE, SC, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zylö Therapeutics has been selected to join the Endless Frontier Labs (EFL)...
Ocean Biomedical Announces Newly Published Findings Demonstrating Ability to Restore Treatment Sensitivity to AstraZeneca’s Leading Lung Cancer Drug After Resistance Has Formed, and Enhanced Tumor Suppression in EGFR-Mutation Lung Cancers
Company to Host Cancer R&D Update on October 19, 2023 to Share Latest Details of Multipronged Cancer Program Based on...
Syneos Health Appoints Colin Shannon as Chief Executive Officer
Industry Veteran Brings Decades of Experience Driving Growth at Global Biopharmaceutical Solutions OrganizationsMORRISVILLE, N.C., Oct. 03, 2023 (GLOBE NEWSWIRE) --...
Neural Therapeutics Announces Board of Directors Appointments and IP Development Agreement with Validity Labs
Toronto, Ontario--(Newsfile Corp. - October 3, 2023) - Neural Therapeutics Inc. ("Neural" or the "Company") is pleased to announce the...